| 12447207 |
Human cytomegalovirus gB polypeptide |
Yuan Liang Liu, Xiaoyuan Sherry Chi, Philip Dormitzer, Jennifer Anne Nicki, Xiaojie Yao |
2025-10-21 |
|
| 12364749 |
RSV F protein mutants |
Philip Dormitzer, Alexey Vyacheslavovich Gribenko, Luke David Handke, Avvari Krishna Prasad, Xiayang Qiu +9 more |
2025-07-22 |
|
| 12357681 |
E. coli FimH mutants and uses thereof |
Laurent Oliver Chorro, Robert George Konrad Donald, Matthew Curtis Griffor, Natalie Clare Silmon de Monerri |
2025-07-15 |
|
| 12077533 |
Pyrrolo[2,3-d]pyrimidinyl, pyrrolo[2,3-b]pyrazinyl and pyrrolo[2,3-d]pyridinyl acrylamides |
Atli Thorarensen, Matthew Frank Brown, Agustin Casimiro-Garcia, Jotham Wadsworth Coe, Mark E. Flanagan +7 more |
2024-09-03 |
$1,055,482,000 |
| 11981696 |
Fluoro-pyridinone phosphates and boronates useful as antibacterial agents |
Tamim F. Braish, Matthew Frank Brown, Richard Andrew Ewin, Timothy Allan Johnson, Michael Joseph Melnick +5 more |
2024-05-14 |
$498,348,000 |
| 11857622 |
Human cytomegalovirus GB polypeptide |
Yuhang Liu, Xiaoyuan Sherry Chi, Philip Dormitzer, Jennifer Anne Nicki, Xiaojie Yao |
2024-01-02 |
$249,725,000 |
| 11712480 |
Heteroaryl sulfone-based conjugation handles, methods for their preparation, and their use in synthesizing antibody drug conjugates |
Russell Dushin, Daniel Paul Uccello, Jeremy Tyson Starr, Mark E. Flanagan, Jeffrey M. Casavant +8 more |
2023-08-01 |
$1,066,643,000 |
| 11629172 |
Human cytomegalovirus gB polypeptide |
Philip Dormitzer, Xiaoyuan Sherry Chi, Seungil Han, Kyle P. HEIM, Thomas R. Jones +6 more |
2023-04-18 |
$1,259,110,000 |
| 11111242 |
Pyrrolo[2,3-d]pyrimidinyl, pyrrolo[2,3-b]pyrazinyl and pyrrolo[2,3-d]pyridinyl acrylamides |
Atli Thorarensen, Matthew Frank Brown, Agustin Casimiro-Garcia, Jotham Wadsworth Coe, Mark E. Flanagan +7 more |
2021-09-07 |
$508,674,000 |
| 10821171 |
RSV F protein mutants |
Philip Dormitzer, Alexey Vyacheslavovich Gribenko, Luke David Handke, Avvari Krishna Prasad, Xiayang Qiu +9 more |
2020-11-03 |
$385,583,000 |
| 10703756 |
Pyrrolo[2,3-D]pyrimidinyl, pyrrolo[2,3-B]pyrazinyl, pyrrolo[2,3-B]pyridinyl acrylamides and epoxides thereof |
Atli Thorarensen, Matthew Frank Brown, Agustin Casimiro-Garcia, Mark E. Flanagan, Adam Matthew Gilbert +5 more |
2020-07-07 |
$1,138,994,000 |
| 10238732 |
RSV F protein mutants |
Philip Dormitzer, Alexey Vyacheslavovich Gribenko, Luke David Handke, Avvari Krishna Prasad, Xiayang Qiu +9 more |
2019-03-26 |
$452,192,000 |
| 9950058 |
RSV F protein mutants |
Philip Dormitzer, Alexey Vyacheslavovich Gribenko, Luke David Handke, Avvari Krishna Prasad, Xiayang Qiu +9 more |
2018-04-24 |
$328,572,000 |
| 9617258 |
Pyrrolo[2,3-d]pyrimidinyl, pyrrolo[2,3-b]pyrazinyl and pyrrolo[2,3-d]pyridinyl acrylamides |
Atli Thorarensen, Matthew Frank Brown, Agustin Casimiro-Garcia, Jotham Wadsworth Coe, Mark E. Flanagan +7 more |
2017-04-11 |
$241,476,000 |
| 9180123 |
N-link hydroxamic acid derivatives useful as antibacterial agents |
Matthew Frank Brown, Anthony Marfat, Michael J. Melnick, Justin Ian Montgomery, Usa Reilly |
2015-11-10 |
$341,611,000 |
| 9018384 |
N-link hydroxamic acid derivatives useful as antibacterial agents |
Matthew Frank Brown, Anthony Marfat, Michael J. Melnick, Justin Ian Montgomery, Usa Reilly |
2015-04-28 |
$642,054,000 |
| 8846933 |
N-link hydroxamic acid derivatives useful as antibacterial agents |
Matthew Frank Brown, Anthony Marfat, Michael Joseph Melnick, Justin Ian Montgomery, Usa Reilly |
2014-09-30 |
$281,207,000 |
| 8779148 |
Fluoro-pyridinone derivatives useful as antibacterial agents |
Usa Reilly, Michael Joseph Melnick, Matthew Frank Brown, Mark Plummer, Justin Ian Montgomery +1 more |
2014-07-15 |
$662,734,000 |
| 8664401 |
N-linked hydroxamic acid derivatives useful as antibacterial agents |
Matthew Frank Brown, Anthony Marfat, Michael Joseph Melnick, Justin Ian Montgomery, Usa Reilly |
2014-03-04 |
$672,881,000 |
| 8624034 |
Fluoro-pyridinone derivatives useful as antibacterial agents |
Usa Reilly, Michael Joseph Melnick, Matthew Frank Brown, Mark Plummer, Justin Ian Montgomery +1 more |
2014-01-07 |
$333,421,000 |
